23rd Nov 2020 18:03
RUA Life Sciences PLC - Ayrshire, Scotland-based medical device business - Notes findings from heart valve testing of Elast-Eon polymers. Says all valves tested "easily surpassed minimum ISO requirements" which means product can work on human hearts. Notes valves tested showed "remarkable consistency in performance". "The RUA surgical valve and Elast-Eon leaflet system have been designed to minimise stress with the objective of increasing the durability of heart valves," RUA says.
Current stock price: 150.00 pence
Year-to-date change: up 49%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Rua Life Sci.